Gainers Shuttle Pharmaceuticals (NASDAQ:SHPH) shares rose 56.1% to $4.62 during Monday's after-

This whale alert can help traders discover the next big trading opportunities. Whales are entities w

Capricor Therapeutics Inc. (NASDAQ:CAPR) stock is trading lower on Friday, down by 13%.

Capricor stock falls after the FDA schedules a July advisory committee meeting for Deramiocel, its D

Capricor Therapeutics (NASDAQ:CAPR), a biotechnology company developing transformative cell and exos

–Advisory Committee meeting scheduled for July 29, 2026– –Company's Biologics License Application on

Capricor Therapeutics (NASDAQ:CAPR), a biotechnology company developing transformative cell and exos

SAN DIEGO, June 26, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology c

Toronto, Ontario--(Newsfile Corp. - June 19, 2026) - Caprock Mining Corp. (CSE: CAPR) ("Caprock" or

Toronto, Ontario--(Newsfile Corp. - June 17, 2026) - Frank Guillemette (the "Acquiror") announces th

Toronto, Ontario--(Newsfile Corp. - June 12, 2026) - Caprock Mining Corp. (CSE: CAPR) ("Caprock" or

Toronto, Ontario--(Newsfile Corp. - June 12, 2026) - Caprock Mining Corp. (CSE: CAPR) ("Caprock", or

Capricor Therapeutics NASDAQ: CAPR executives said the company is in active discussions with the U.S

Capricor Therapeutics, Inc. (CAPR) Presents at Goldman Sachs 47th Annual Global Healthcare Conferenc

SAN DIEGO, June 08, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology c

Capricor is rated a speculative Buy ahead of its August 22 PDUFA for deramiocel in Duchenne muscular

Capricor Therapeutics, Inc. (CAPR) Q1 2026 Earnings Call Transcript

Capricor Therapeutics NASDAQ: CAPR said its Duchenne muscular dystrophy therapy candidate deramiocel

Deramiocel BLA under active FDA review; PDUFA target action date of August 22, 2026; labeling discus

Focused on advanced cell therapies for rare diseases, this biotech firm reported a notable insider s

Capricor Therapeutics Inc. (NASDAQ:CAPR) on Thursday filed a lawsuit against Nippon Shinyaku Co., Lt

– Company to Host Conference Call on May 12, 2026, at 4:30 p.m. ET – SAN DIEGO, May 04, 2026 (GLOBE

Capricor Therapeutics, Inc. (NASDAQ: CAPR - Get Free Report) CFO Anthony Bergmann sold 25,000 shares

Capricor Therapeutics, Inc. (NASDAQ: CAPR - Get Free Report) Director Karimah Es Sabar sold 61,265 s

Capricor Therapeutics, Inc. (NASDAQ: CAPR - Get Free Report) Director Karimah Es Sabar sold 53,735 s

Dow Jones index up 200 points on Tuesday, NIO Inc. gained following better-than-expected financial r

FDA biologics chief Vinay Prasad will leave in April, lifting biotech stocks such as uniQure, Capric

Here's a look at this week's earnings reports that are most likely to be watched by retail i

  On Tuesday, 647 companies set new 52-week lows.

  On Monday, 369 companies set new 52-week lows.

  Companies Reporting Before The Bell • Anavex Life Sciences (NASDAQ:AVXL) is estimated to report

  Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report

  Companies Reporting Before The Bell • Celsius Holdings (NASDAQ:CELH) is estimated to report quar

Stocks Which Set New 52-Week Low Friday, October 26th

Stocks Which Set New 52-Week Low Yesterday, October 23rd

Stocks Which Set New 52-Week Low Yesterday, October 10th

Stocks Which Set New 52-Week Low Yesterday, October 9th